APVO-2022-01-21 8K

Company

Aptevo Therapeutics Inc.

Filed

January 21, 2022

Period of Report

January 21, 2022

Accession Number

0001564590-22-001848

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →